Status

n.v.

beendet

Teilen

Finanzierungsdaten (05/05/2021)

Finanziert
EUR 2.227.944,00
Finanzierungsschwelle
EUR 2.000.000,00

Einzelheiten

Land
Afghanistan AF
Typologie
EigenkapitalEquity
Endtermin
05/05/2021 (1135 Tage)

Beschreibung

“Blood vessel occlusions occur at the vascular injury sites and play a key role in many diseases, inc. diabetes, COVID-19/sepsis and peripheral artery disease.AplagonÔÇÖs product APAC uniquely prevents blood vessel occlusions at vascular injury sites.”

Fortschritte bei der Finanzierung

Projektvorschau